Skip to main content
. 2021 Dec 9;59:100794. doi: 10.1016/j.drup.2021.100794

Table 5.

A summary of COVID-19 drug effectiveness meta-analyses.

Drug No. patients Outcome Effect
Vitamin D (Rawat et al., 2021) 467 Mortality reduction No effect; R = 0.55 (95 % CI 0.22–1.39), p = 0.21
HCQ (Amani et al., 2021) 6059 Mortality reduction No effect, RR = 0.7 (95 % CI: 0.24–1.99)
HCQ (Bartoszko et al., 2021) 8161 Side effects RR = 1.81 (95 % CI: 1.36–2.42), p < 0.05
HCQ (Axfors et al., 2021) 10,012 Increase of mortality OR = 1.11 (95 % CI: 1.02–1.20)
Convalescent plasma (Bansal et al., 2021b) 27,706 Mortality reduction OR 0.76 (95 % CI: 0.53–1.08), p = 0.13
Sarilumab (Lescure et al., 2021b) 416 Positive effect HR = 1.03 (95 % CI 0.75–1.40]; p = 0.96

Legend: HCQ – hydroxychloroquine; HR – hazard ratio; OR – odds ratio; RR – risk ratio; 95 % Cl – 95 % confidence interval.